James Herron, Ph.D.

RESEARCH INTERESTS

Dr. Herron is interested in translational research – specifically, translating innovative near-patient diagnostics technologies from the laboratory into the clinic. Presently, his research is focused in three areas: 

1) optical biosensor applications in biodefense, diagnostics, companion diagnostics, environmental and food testing, and personalized medicine; 

2) high-throughput homogeneous fluorescence assays for use in biodefense, diagnostics, and quality control and assurance; and 

3) dynamic light scattering as a means of detecting intravenous (IV) drug incompatibilities, when co-administered through the same IV line. He has published 113 full-length research articles and 107 abstracts. 

He also edited a book entitled “Physical Methods to Characterize Pharmaceutical Proteins.” 

Dr. Herron has 32 US and 41 foreign patents and has co-founded three different point-of-care diagnostics companies to commercialize biosensor technology developed in his laboratory. He has also consulted for 3M Corporation, Abbott Laboratories, Agri-Analysis, ARUP Laboratories, Echelon Biosciences, Johnson & Johnson, Kansas Technology Enterprise Corporation, and mBio Diagnostics. He also chaired the translational development subcommittee of the Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease (RMRCE), a NIH-sponsored center that supports basic and translational research in biodefense and infectious disease, with focus on developing countermeasures for both.

RELATED LINKS